Skip to main content
. 2021 Jan 21;19:39. doi: 10.1186/s12967-021-02701-z

Fig. 4.

Fig. 4

High C3M/PRO-C3 ratio was predictive of treatment-specific OS in Stage 2 of HALO 109-202 using Stage 1 cut-offs. C3M/PRO-C3 ratio subgroups defined by a median cut-off derived from Stage 1 and b ROC cut-off derived from Stage 1